Literature DB >> 856015

Susceptibility of anaerobic bacteria to metronidazole, ornidazole, and tinidazole and routine susceptibility testing by standardized methods.

J Wust.   

Abstract

A total of 114 strains of anaerobic bacteria were examined for their susceptibility to metronidazole, ornidazole, and tinidazole by measuring the minimum inhibitory concentration (MIC) and minimum bactericidal concentration in different media. All strains, with the exception of the isolates of Propionibacterium acnes, were inhibited by 3.1 mug each and killed by 6.3 mug each of all three nitroimidazole compounds per ml. No significant differences in MIC values were found among metronidazole, ornidazole, and tinidazole. Only minor differences were detected by comparing MIC values obtained in brain heart infusion agar with and without sheep blood, brucella agar, and Mueller-Hinton agar (both containing blood). When the strains were tested by the modified broth-disk method proposed by the Anaerobe Laboratory of the Virginia Polytechnic Institute (VPI), there was good correlation with the MIC values (97.4% agreement for metronidazole and 94.7% for ornidazole and tinidazole). For routine testing, use of a 30-mug-class disk of either nitroimidazole derivative is proposed for the broth-disk method, resulting in a final concentration of 6 mug/ml in the test tubes, a concentration easily attainable in body fluids. In contrast to the broth-disk method, there was very poor correlation between inhibition zone diameters by the standardized VPI agar diffusion test and MIC values.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 856015      PMCID: PMC352041          DOI: 10.1128/AAC.11.4.631

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

1.  Treatment with metronidazole of three patients with serious infections due to Bacteroides fragilis.

Authors:  H R Ingham; G E Rich; J B Selkon; J H Hale; C M Roxby; M J Betty; R W Johnson; P R Uldall
Journal:  J Antimicrob Chemother       Date:  1975-06       Impact factor: 5.790

2.  Combined agar diffusion and replica plating techniques in the study of antibacterial substances.

Authors:  S D ELEK; G R HILSON
Journal:  J Clin Pathol       Date:  1954-02       Impact factor: 3.411

3.  Susceptibility testing of anaerobic bacteria with 100-microg carbenicillin disks.

Authors:  W W Laslie; D W Lambe
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

4.  Anaerobic infections. 1.

Authors:  S L Gorbach; J G Bartlett
Journal:  N Engl J Med       Date:  1974-05-23       Impact factor: 91.245

5.  Modified broth-disk method for testing the antibiotic susceptibility of anaerobic bacteria.

Authors:  T D Wilkins; T Thiel
Journal:  Antimicrob Agents Chemother       Date:  1973-03       Impact factor: 5.191

6.  Antimicrobial susceptibilities of anaerobic bacteria: recent clinical isolates.

Authors:  J L Staneck; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

7.  Inadequate antibody response to HBAg or suppressor T-cell defect in development of active chronic hepatitis.

Authors: 
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

8.  Proposed standardized method for testing and interpreting susceptibility of Bacteroides fragilis to tetracycline.

Authors:  S Overman; D W Lambe; J V Bennett
Journal:  Antimicrob Agents Chemother       Date:  1974-04       Impact factor: 5.191

9.  Susceptibility of Clostridium ramosum to antimicrobial agents.

Authors:  F P Tally; A Y Armfield; V R Dowell; Y Y Kwok; V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1974-06       Impact factor: 5.191

10.  Inhibition of Bacteroides fragilis on blood agar plates and reversal of inhibition by added hemin.

Authors:  T D Wilkins; S L Chalgren; F Jimenez-Ulate; C R Drake; J L Johnson
Journal:  J Clin Microbiol       Date:  1976-03       Impact factor: 5.948

View more
  15 in total

1.  Pharmacokinetics of ornidazole in neonates and infants after a single intravenous infusion.

Authors:  A Turcant; J C Granry; P Allain; M Cavellat
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

2.  Comparative activity of metronidazole and tinidazole against Clostridium difficile and Peptostreptococcus anaerobius.

Authors:  A M Jokipii; L Jokipii
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

3.  Pharmacokinetics of metronidazole in patients undergoing peritoneal dialysis.

Authors:  J G Cassey; D A Clark; P Merrick; B Jones
Journal:  Antimicrob Agents Chemother       Date:  1983-12       Impact factor: 5.191

4.  Bile and serum levels of tinidazole after a single oral dose.

Authors:  P S Hunt; A J Davidson; J Alden; S Cheng
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

Review 5.  Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.

Authors:  K C Lamp; C D Freeman; N E Klutman; M K Lacy
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

6.  Propionibacteria as a cause of shunt and postneurosurgical infections.

Authors:  P R Skinner; A J Taylor; H Coakham
Journal:  J Clin Pathol       Date:  1978-11       Impact factor: 3.411

7.  [Antibiotic resistance of anaerobic bacteria (author's transl)].

Authors:  W Niederau; U Höffler; G Pulverer
Journal:  Infection       Date:  1982       Impact factor: 3.553

Review 8.  Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

Review 9.  Tinidazole in anaerobic infections: a review of its antibacterial activity, pharmacological properties and therapeutic efficacy.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-08       Impact factor: 9.546

10.  Intravenous metronidazole for treatment of infections involving anaerobic bacteria.

Authors:  W L George; B D Kirby; V L Sutter; L A Wheeler; M E Mulligan; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.